Скачать или смотреть স্কয়ারফার্মা কি আন্ডারভ্যালুড? SQURPHARMA DCF Valuation & Quantitative Analysis

📅 Book a 1 hour live Google Meet session with me:
https://rafyq101.notion.site/Finance-...

For sponsors or Google Meet session:
✉️ [email protected]

In this video, we take a data driven and quantitative approach to analyze Square Pharmaceuticals Ltd (SQURPHARMA) and answer one key question for Bangladeshi investors.

স্কয়ার ফার্মা কি আন্ডারভ্যালুয়েড নাকি ওভারভ্যালুয়েড?

Instead of opinions or market noise, this analysis focuses purely on valuation logic, numbers, and peer comparison using multiple proven valuation frameworks relevant to the Dhaka Stock Exchange and the pharmaceutical sector.

What we covered in this video:

Square Pharmaceuticals quantitative and valuation analysis covering
• Overall pharmaceutical industry outlook
• Relative valuation and peer comparison
• Dividend Discount Model valuation
• Peter Lynch PEGY based valuation
• Discounted Cash Flow valuation
• Mutual fund accumulation price analysis
• Summary and conclusion

🔹 Relative Valuation and Peer Comparison

We compare SQURPHARMA with major listed pharmaceutical companies on the DSE including
BXPHARMA, RENATA, ACMELAB, ACI, IBNSINA, BEACONPHAR, ORIONPHARM, NAVANAPHAR, and SILVAPHL
to understand how Square Pharmaceuticals is priced relative to its peers.

🔹 Dividend Discount Model Valuation

Intrinsic value estimation based on sustainable dividend growth and long term assumptions.

🔹 Peter Lynch PEGY Based Valuation

Growth adjusted valuation combining earnings growth and dividend yield to assess whether SQURPHARMA is undervalued.

🔹 Discounted Cash Flow Valuation

Intrinsic value calculation using projected future cash flows.

🔹 Mutual Fund Accumulation Price Analysis

Analysis of mutual fund buying behavior and accumulation zones to identify price levels where institutional investors showed interest.

Mutual funds mentioned in this video:

• EDGE AMC Growth Fund
• VIPB SEBL 1st Unit Fund
• CWT Growth Fund
• Shanta First Income Unit Fund
• UCB AML First Mutual Fund
• IDLC Growth Fund
• Investit Growth Fund

🔹 Summary and Conclusion

All valuation models are combined to form a balanced long term investment view on Square Pharmaceuticals.

This video is useful if you are:

• A DSE investor analyzing pharmaceutical stocks
• Interested in quantitative and valuation based investing
• Comparing SQURPHARMA with RENATA, BXPHARMA, and other pharma peers
• Focused on long term fundamentals rather than short term price movements

Important Note

This video focuses on valuation, relative pricing, and quantitative logic. It does not predict short term price movement.
Join our Bangladesh investing communities:
I regularly share investment ideas, valuation discussions, and Bangladesh market insights in the following Facebook groups.

💊 SQURPHARMA Investors Bangladesh
  / squrpharma  

💧 MARICO Investors Bangladesh
  / maricobangladesh  

🚬 BATBC Investors Bangladesh
  / batbc  

🏦 DSE Bank Investors Bangladesh
  / dsebank  

💼 HNI Bangladesh
  / hnibd  

😀 FIRE BD – Financial Independence Bangladesh
  / firebangladesh  

If you found this video helpful

👍 Like the video
💬 Comment your view on SIP
🔔 Subscribe for more Bangladesh focused investing content

Disclaimer
This video is for educational purposes only. This is not financial advice. Please do your own research before making any investment decisions.